Novartis $1.7Bn deal with UK bio9 Dec 2025 15:20
FAB's future ?
LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Relation today announced a multi-program, strategic collaboration with Novartis to discover and advance novel targets for atopic diseases.
Under the terms of the agreement, Relation will receive $55 million, comprising an upfront payment, equity investment and additional R&D funding. In addition, Relation is eligible to receive preclinical, development, regulatory, and commercial sales milestones of up to $1.7 billion, along with tiered royalties on net sales of products.
The collaboration pairs Relation’s AI-powered drug discovery platform and human data generation capabilities with Novartis’s deep expertise in immuno-dermatology to identify, validate, and advance potential first-in-class targets in atopic diseases driven by immune dysregulation.